LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Generated: 2026-11-17
Case ID: NM_001127208.3_c.5192del_20261117_015159
Framework: ACMG/AMP 2015
Variant classification summary

NM_001127208.3:c.5192del

TET2  · NP_001120680.1:p.(Gly1731AlafsTer14)  · NM_001127208.3
GRCh37: chr4:106196857 TG>T  ·  GRCh38: chr4:105275700 TG>T
Gene: TET2 Transcript: NM_001127208.3
Final call
VUS
PVS1 strong PM2 supporting
All criteria require review: For research and educational purposes only.
Gene
TET2
Transcript
NM_001127208.3
Protein
NP_001120680.1:p.(Gly1731AlafsTer14)
gnomAD AF
ClinVar
OncoKB
Likely Oncogenic
Interpretation summary
Generated evidence synthesis
1
PVS1 strong: the terminal-exon frameshift is predicted to truncate TET2 and escape canonical NMD.
2
PM2 supporting: the variant is absent from gnomAD v2.1 and v4.1.
Final determination: Under the generic ACMG/AMP 2015 fallback, one strong pathogenic criterion plus one supporting criterion does not meet a Likely Pathogenic or Pathogenic combination rule, and no benign rule is satisfied, resulting in VUS.
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
Criterion Status Rationale Evidence used
PVS1 Met Strong: The frameshift in exon 11 of 11 is predicted to escape NMD, so PVS1 is downgraded from very strong under the NMD-escape rule.
pvs1_gene_context pvs1_variant_assessment pvs1_generic_framework
PS1 N/A Not applicable: PS1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PS2 Not assessed Not assessed: confirmed maternity, paternity, proband disease status, and absence of family history are not documented.
PS3 Not assessed Not assessed: no validated assay directly tested c.5192del, and the available study assayed different TET2 mutants rather than this variant.
PMID:21057493
PS4 Not assessed Not assessed: no variant-specific affected-case/control counts, odds ratio, or 95% confidence interval were available to test the PS4 threshold OR > 5.0 with CI excluding 1.0.
PMID:21057493
PM1 N/A Not applicable: PM1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM2 Met Met at supporting strength: the variant is absent from gnomAD v2.1 and v4.1, satisfying the supplied PM2 frequency threshold of <=0.0001.
gnomad_v2 gnomad_v4
PM3 Not assessed Not assessed: no documented pathogenic allele in trans or parent/offspring testing establishes phase for this variant.
PM4 N/A Not applicable: PM4 requires a protein-length change, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
PM5 N/A Not applicable: PM5 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PM6 Not assessed Not assessed: no documented assumed de novo occurrence or parental testing is available for the proband.
PP1 Not assessed Not assessed: no affected relatives, familial testing results, cosegregation observations, or informative meioses are documented.
PP2 N/A Not applicable: PP2 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
PP3 N/A Not applicable: c.5192del is a frameshift predicted to cause p.(Gly1731AlafsTer14), outside PP3's missense or splice-region/intronic scope.
PP4 Not assessed Not assessed: the patient's phenotype and family history were not provided, so phenotype specificity for a single-gene disease cannot be evaluated.
PP5 Not met Not met: ClinVar has no exact-variant record or expert-panel Pathogenic/Likely pathogenic classification to support PP5.
clinvar
BA1 Not met Not met: gnomAD v2.1 and v4.1 report the variant absent, with no grpmax FAF reaching the BA1 threshold of 0.05.
gnomad_v2 gnomad_v4
BS1 Not met Not met: gnomAD v2.1 and v4.1 report no observed alleles, so no grpmax FAF exceeds the generic BS1 threshold of 0.01.
gnomad_v2 gnomad_v4
BS2 Not assessed Not assessed: no healthy-adult carrier or homozygote observation is reported, and early-age full penetrance is not established for this disorder.
gnomad_v2 gnomad_v4
BS3 Not assessed Not assessed: no direct functional study shows that c.5192del has no damaging effect on TET2 function or splicing.
PMID:21057493
BS4 Not assessed Not assessed: no affected relatives with negative variant testing or pedigree evidence demonstrates lack of segregation.
BP1 N/A Not applicable: BP1 requires a missense variant, and this is a frameshift variant.
generic_acmg_combination_rules
BP2 Not assessed Not assessed: no phase-resolved observation shows a pathogenic variant in cis or, for a fully penetrant dominant disorder, in trans.
BP3 N/A Not applicable: BP3 requires an in-frame indel in a repeat region, and this is a frameshift variant.
pvs1_generic_framework generic_acmg_combination_rules
BP4 N/A Not applicable: the frameshift predicts p.(Gly1731AlafsTer14), so SpliceAI max delta 0.011 cannot establish no gene-product impact under BP4.
BP5 Not met Not met: COSMIC reports one somatic occurrence, but no case with an established alternate molecular basis for the disease was documented.
cosmic
BP6 Not met Not met: ClinVar has no exact-variant record or expert-panel Benign/Likely benign classification to support BP6.
clinvar
BP7 N/A Not applicable: BP7 requires a synonymous variant, and this is a frameshift variant.
generic_acmg_combination_rules
Disclaimer: The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.